Literature DB >> 10443553

Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease.

M Bigl1, M K Brückner, T Arendt, V Bigl, K Eschrich.   

Abstract

The activities of hexokinase, aldolase, pyruvate kinase, lactate dehydrogenase and glucose 6-phosphate dehydrogenase were determined in brains of patients with Alzheimer's disease (AD) and in age matched controls. For pyruvate kinase and lactate dehydrogenase a significant increase in specific activity was found in frontal and temporal cortex of AD brains, while the activities of aldolase and hexokinase are not changed. Glucose 6-phosphate dehydrogenase activity was significantly reduced in hippocampus. The increase of some glycolytic enzyme activities is correlated with increased contents of lactate dehydrogenase and glial fibrillary acidic protein (GFAP) in homogenates of frontal and temporal cortex and elevated phosphofructokinase (PFK) and GFAP in astrocytes from the same brain areas. The data extend previous findings on an increase in brain PFK specific activity in AD and suggest that the increased activity of some glycolytic enzymes may be, at least in part, the result of the reactive astrocytosis developing in the course of AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443553     DOI: 10.1007/s007020050174

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  48 in total

1.  Effects of acupuncture on glycometabolic enzymes in multi-infarct dementia rats.

Authors:  Lan Zhao; Peng Shen; Yingying Han; Xuezhu Zhang; Kun Nie; Haiyan Cheng; Bohong Kan; Guomin Li; Jianchun Yu; Jingxian Han
Journal:  Neurochem Res       Date:  2011-01-30       Impact factor: 3.996

Review 2.  Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations.

Authors:  Judit Ovádi; Ferenc Orosz; Susan Hollán
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 3.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

4.  Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity.

Authors:  Wen Fu; Diya Shi; David Westaway; Jack H Jhamandas
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

Review 5.  Alzheimer disease--no target for statin treatment. A mini review.

Authors:  Siegfried Hoyer; Peter Riederer
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

6.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

7.  Effect of physical exercise on changes in activities of creatine kinase, cytochrome c oxidase and ATP levels caused by ovariectomy.

Authors:  Cassiana Siebert; Janaína Kolling; Emilene B S Scherer; Felipe Schmitz; Maira Jaqueline da Cunha; Vanize Mackedanz; Rodrigo B de Andrade; Clovis M D Wannmacher; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2014-05-10       Impact factor: 3.584

8.  Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.

Authors:  Mark A Lovell; Shuling Xiong; William R Markesbery; Bert C Lynn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 9.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

10.  Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology.

Authors:  Joy G Mohanty; Hem D Shukla; Jefferey D Williamson; Lenore J Launer; Satya Saxena; Joseph M Rifkind
Journal:  Proteome Sci       Date:  2010-03-03       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.